CCR2 and neoplasm: Although L-MSCs behave not differently from BM-MSCs in their effects on adaptive immune cells, they are more effective in recruiting monocytes/macrophages via CCR2, which positions L-MSCs a much stronger tumor-promoting population than BM-MSCs.